n,n-dimethylarginine has been researched along with Apoplexy in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (27.78) | 29.6817 |
| 2010's | 26 (72.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arós, F; Clish, CB; Corella, D; Estruch, R; Fitó, M; Gómez-Gracia, E; Guasch-Ferré, M; Hruby, A; Hu, FB; Lapetra, J; Liang, L; Martínez-González, MA; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Toledo, E; Wang, DD; Yu, E | 1 |
| Bang, OY; Cho, YH; Chung, CS; Chung, JW; Kim, GM; Lee, KH; Moon, GJ; Oh, MJ | 1 |
| Abusoglu, S; Akbulut, D; Bal, C; Celik, HT; Ercan, M; Güzel, I; Mungan, S; Oguz, EF; Yilmaz, FM | 1 |
| Atzler, D; Böger, RH; Choe, CU; Cordts, K; Gerloff, C; Grant, PJ; Grzybowski, R; Hornig, S; Lezius, S; Lüneburg, N; Magnus, T; Neu, A; Schwedhelm, E; Thomalla, G | 1 |
| Chen, S; Deb-Chatterji, M; Dong, Q; Kielstein, JT; Li, N; Weissenborn, K; Worthmann, H | 1 |
| Bode-Böger, SM; Ehrenreich, H; Hecker, H; Joumaah, M; Kielstein, JT; Li, N; Lichtinghagen, R; Martens-Lobenhoffer, J; Weissenborn, K; Worthmann, H | 1 |
| Chang, SL; Chao, TF; Chen, SA; Hsieh, MH; Hu, YF; Lin, YJ; Lo, LW; Lu, TM; Tsao, HM; Tuan, TC | 1 |
| Abe, A; Inagaki, H; Katayama, Y; Kawada, T; Muraga, K; Nishiyama, Y; Otsuka, T; Ueda, M | 1 |
| Abe, A; Katayama, Y; Muraga, K; Nishiyama, Y; Otsuka, T; Ueda, M | 1 |
| Li, X; Ma, JP; Wang, JZ; Wang, L; Wu, CJ; Xia, XS | 1 |
| Alasady, M; Chakrabarty, A; Lau, DH; Lim, HS; Roberts-Thomson, KC; Sanders, P; Schultz, C; Willoughby, SR; Worthley, MI; Young, GD | 1 |
| Anderssohn, M; Benjamin, EJ; Bernges, I; Blankenberg, S; Böger, RH; Carter, AM; Chen, MH; Erdmann, J; Fornage, M; Gieger, C; Glazer, NL; Grant, PJ; Heckbert, SR; Ikram, MA; Illig, T; Kittel, A; König, IR; König, J; Lackner, K; Lieb, W; Loley, C; Longstreth, WT; Lüneburg, N; Lunetta, KL; Maas, R; Meisinger, C; Munzel, T; Ojeda, FM; Psaty, BM; Schillert, A; Schunkert, H; Schwedhelm, E; Seshadri, S; Smith, N; Sticht, H; Sullivan, LM; Vasan, RS; Wang, TJ; Wichmann, HE; Wiggins, KL; Wild, PS; Xanthakis, V; Zeller, T; Ziegler, A | 1 |
| Fan, D; Zhang, N; Zhang, Y | 1 |
| Chowdhury, R; Chowdhury, S; Di Angelantonio, E; Freitag, DF; Gobin, R; Laukkanen, JA; Mayr, M; Willeit, P | 1 |
| Manolov, VE; Petrova, JJ; Tzatchev, KN; Vasilev, VG; Zlatareva, DK | 1 |
| Blinova, TV; Bondareva, EA; Emanuel, VL; Emanuel, YV; Kharitonova, TV; Kholopova, IV; Lapin, SV; Lazareva, NM; Melnikova, EV; Shmonin, AA; Solovyeva, LN; Stolyarov, MS | 1 |
| Bauersachs, J; Bavendiek, U; Bledau, N; Haghikia, A; Hanff, E; Kayacelebi, AA; Sonnenschein, K; Tsikas, D; Weissenborn, K; Widera, C; Yanchev, GR | 1 |
| Brouns, R; De Deyn, PP; Marescau, B; Possemiers, I; Sheorajpanday, R | 1 |
| Atzler, D; Böger, RH; Choe, CU; Gelderblom, M; Gerloff, C; Leypoldt, F; Magnus, T; Schwedhelm, E; Sydow, K; von Leitner, EC | 1 |
| Christenson, RH; Saenger, AK | 1 |
| Abe, A; Katayama, Y; Katsura, K; Nagayama, H; Nishiyama, Y; Otsuka, T; Ueda, M | 2 |
| Ding, H; Hui, R; Lu, Z; Shaffer, JR; Wang, DW; Wang, H; Wang, X; Wu, B; Yan, J | 1 |
| Bentley, P; Sharma, P | 1 |
| Christopher, R; Mamatha, SN; Nagaraja, D; Philip, M | 1 |
| Chung, MY; Hsu, CP; Lin, CC; Lin, SJ; Lu, TM | 1 |
| Böger, RH; Lüneburg, N; Maas, R; Schwedhelm, E; Töpper, RF; von Holten, RA | 1 |
| Alasady, M; Brooks, AG; Gan, C; Kalman, JM; Kistler, PM; Lau, DH; Leong, DP; Lim, HS; Sanders, P; Schultz, C; Willoughby, SR; Worthley, MI; Young, GD | 1 |
| Faraci, FM; Lentz, SR | 1 |
| Böger, RH | 1 |
| Nishio, I; Tsuda, K | 1 |
| Laaksonen, R; Valkonen, VP | 1 |
| Akita, Y; Fujimoto, S; Koga, Y; Matsuishi, T; Nishioka, J; Povalko, N; Tanabe, Y; Yatsuga, S | 1 |
| Brattström, L; Brudin, L; Carlsson, M; Nilsson, I; Palmqvist, P; Teerlink, T; Wanby, P | 1 |
| Bengtsson, C; Björkelund, C; Fogarty, J; Graham, I; Leong, T; Lissner, L; Thelle, D; Ward, D; Zylberstein, D | 1 |
| Lee, SC; Yoo, JH | 1 |
5 review(s) available for n,n-dimethylarginine and Apoplexy
| Article | Year |
|---|---|
Asymmetric dimethyarginine as marker and mediator in ischemic stroke.
Topics: Animals; Arginine; Biomarkers; Brain Ischemia; Cerebrovascular Circulation; Enzyme Inhibitors; Humans; Methylation; Nitric Oxide Synthase; Oxidative Stress; Protein Processing, Post-Translational; Stroke | 2012 |
Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies.
Topics: Arginine; Cardiovascular Diseases; Humans; Odds Ratio; Prospective Studies; Stroke | 2015 |
Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Arginine; Biomarkers; Diffusion Magnetic Resonance Imaging; Glial Fibrillary Acidic Protein; Humans; Matrix Metalloproteinase 9; Nerve Growth Factors; Prognosis; Receptors, N-Methyl-D-Aspartate; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Stroke; Tomography, X-Ray Computed | 2010 |
[Asymmetrical methylarginine (ADMA) as a cardiovascular risk factor: epidemiological and prospective data].
Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine; Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cells, Cultured; Child; Coronary Disease; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Female; Free Radicals; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Nitric Oxide Synthase; Oxidative Stress; Pre-Eclampsia; Pregnancy; Prospective Studies; Rabbits; Regression Analysis; Renal Dialysis; Risk Factors; Stroke | 2004 |
Asymmetric dimethylarginine (ADMA) and acute vascular events.
Topics: Acute Disease; Angina Pectoris; Arginine; Cardiovascular Diseases; Humans; Myocardial Infarction; Stroke | 2004 |
4 trial(s) available for n,n-dimethylarginine and Apoplexy
| Article | Year |
|---|---|
Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke.
Topics: Acute Disease; Aged; Aged, 80 and over; Arginine; Double-Blind Method; Drug Therapy, Combination; Erythropoietin; Female; Humans; Male; Middle Aged; Severity of Illness Index; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2013 |
Supplementation of folic acid and vitamin B₁₂ reduces plasma levels of asymmetric dimethylarginine in patients with acute ischemic stroke.
Topics: Aged; Arginine; Blood Chemical Analysis; Brain Ischemia; Dietary Supplements; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Stroke; Time Factors; Treatment Outcome; Vitamin B 12 | 2014 |
Statin treatment decreased serum asymmetric dimethylarginine (ADMA) levels in ischemic stroke patients.
Topics: Aged; Aged, 80 and over; Arginine; Atherosclerosis; Atorvastatin; Brain Ischemia; Cholesterol, LDL; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Linear Models; Male; Middle Aged; Pravastatin; Prospective Studies; Pyrroles; Quinolines; Stroke | 2011 |
L-arginine improves the symptoms of strokelike episodes in MELAS.
Topics: Administration, Oral; Adolescent; Adult; Amino Acids; Arginine; Cerebral Arteries; Child; Child, Preschool; Cholesterol; Cyclic GMP; Female; Headache; Humans; Male; MELAS Syndrome; Nitric Oxide; Paresis; Seizures; Stroke; Treatment Outcome; Vasodilation; Vision Disorders; Vomiting | 2005 |
27 other study(ies) available for n,n-dimethylarginine and Apoplexy
| Article | Year |
|---|---|
Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study.
Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Chromatography, Liquid; Citrulline; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; omega-N-Methylarginine; Ornithine; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Tandem Mass Spectrometry | 2017 |
Distinct Roles of Endothelial Dysfunction and Inflammation in Intracranial Atherosclerotic Stroke.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Arginine; Biomarkers; Endothelium; Female; Humans; Inflammation; Intracranial Arteriosclerosis; Male; Middle Aged; Stroke | 2017 |
Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke.
Topics: Aged; Aged, 80 and over; Arginine; Brain Ischemia; Female; Humans; Male; Middle Aged; Nitric Oxide; Stroke | 2019 |
Guanidino compound ratios are associated with stroke etiology, internal carotid artery stenosis and CHA
Topics: Aged; Arginine; Biomarkers; Brain Ischemia; Carotid Arteries; Carotid Stenosis; Cross-Sectional Studies; Female; Homoarginine; Humans; Intracranial Hemorrhages; Male; Middle Aged; Recurrence; Stroke | 2019 |
Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram.
Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Cardiovascular Diseases; Coronary Angiography; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Referral and Consultation; Risk Assessment; Risk Factors; Stroke; Survival Rate; Time Factors | 2013 |
Asymmetric dimethylarginine is related to the predicted stroke risk in middle-aged Japanese men.
Topics: Adult; Aged; Arginine; Humans; Linear Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Stroke; Surveys and Questionnaires; Young Adult | 2014 |
The asymmetric dimethylarginine level is associated with the predicted stroke risk in Japanese women.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Japan; Middle Aged; Odds Ratio; Prognosis; Risk Factors; Stroke | 2014 |
Successful catheter ablation decreases platelet activation and improves endothelial function in patients with atrial fibrillation.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Catheter Ablation; Electrocardiography; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Integrin beta3; Male; Middle Aged; P-Selectin; Platelet Activation; Prospective Studies; Recurrence; Stroke | 2014 |
Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine.
Topics: Adult; Aged; Amidohydrolases; Arginine; Binding Sites; Cohort Studies; Female; Genetic Loci; Genome-Wide Association Study; Genotype; HEK293 Cells; Humans; Male; Mediator Complex; Middle Aged; Polymorphism, Single Nucleotide; Protein Structure, Tertiary; Risk Factors; Stroke; Substrate Specificity; Transaminases | 2014 |
[The relationship between serum asymmetric dimethylarginine and ABCD2 score in transient ischemic attack patients].
Topics: Arginine; Case-Control Studies; Cerebral Infarction; Humans; Ischemic Attack, Transient; Risk Factors; Stroke | 2014 |
ADMA--a Possible Marker for Early Therapeutic Outcome in Acute Stroke.
Topics: Aged; Arginine; Biomarkers; Female; Humans; Male; Middle Aged; Stroke; Thrombolytic Therapy | 2015 |
[THE CLINICAL LABORATORY MARKERS OF ATHEROSCLEROSIS IN PATIENTS WITH ATHEROTHROMBOTIC STROKE].
Topics: Aged; Aged, 80 and over; Arginine; Atherosclerosis; Biomarkers; C-Reactive Protein; Carotid Stenosis; Case-Control Studies; Female; Humans; Male; Middle Aged; Phospholipases A2; Pregnancy-Associated Plasma Protein-A; Stroke | 2015 |
The role of L-arginine/L-homoarginine/nitric oxide pathway for aortic distensibility and intima-media thickness in stroke patients.
Topics: Aorta; Arginine; Atherosclerosis; Endothelium, Vascular; Female; Homoarginine; Humans; Male; Middle Aged; Nitric Oxide; Stroke; Ultrasonography; Vascular Remodeling | 2017 |
Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity.
Topics: Aged; Arginine; Brain Ischemia; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Stroke | 2009 |
Dimethylarginine dimethylaminohydrolase-1 transgenic mice are not protected from ischemic stroke.
Topics: Amidohydrolases; Animals; Arginine; Brain; Endothelium, Vascular; Genotype; Infarction, Middle Cerebral Artery; Ischemia; Male; Mice; Mice, Transgenic; Models, Biological; Nitric Oxide; Stroke | 2009 |
Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke.
Topics: Age Factors; Aged; Arginine; Biomarkers; Blood Glucose; Brain Ischemia; Cholesterol, LDL; Dyslipidemias; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity; Stroke; Up-Regulation | 2010 |
A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease.
Topics: Aged; Amidohydrolases; Arginine; Asian People; Binding Sites; Biomarkers; Case-Control Studies; Cells, Cultured; Chi-Square Distribution; China; Coronary Artery Disease; DNA Mutational Analysis; DNA-Binding Proteins; Female; Gene Expression Regulation, Enzymologic; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Mutagenesis, Insertional; Odds Ratio; Phenotype; Polymorphism, Genetic; Promoter Regions, Genetic; Risk Assessment; Risk Factors; Sequence Deletion; Stroke; Thrombosis; Transcription Factor MTF-1; Transcription Factors; Transcriptional Activation; Transfection | 2010 |
Down but not out: candidate gene-based studies still have value in a world dominated by whole genome approaches.
Topics: Amidohydrolases; Arginine; Asian People; Biomarkers; China; Coronary Artery Disease; Evidence-Based Medicine; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Phenotype; Polymorphism, Genetic; Promoter Regions, Genetic; Risk Factors; Stroke; Thrombosis | 2010 |
Asymmetric dimethylarginine as a risk marker for early-onset ischemic stroke in Indian population.
Topics: Adolescent; Adult; Analysis of Variance; Arginine; Biomarkers; Brain Ischemia; Case-Control Studies; Female; Humans; India; Linear Models; Male; Middle Aged; Risk; Stroke; Time Factors; Young Adult | 2011 |
Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease.
Topics: Aged; Aged, 80 and over; Albuminuria; Arginine; Biomarkers; Chi-Square Distribution; Chromatography, High Pressure Liquid; Disease-Free Survival; Female; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke; Taiwan; Time Factors | 2011 |
Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Brain Ischemia; Chromatography, Liquid; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Kidney; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Prognosis; Proportional Hazards Models; Stroke; Tandem Mass Spectrometry; Time Factors | 2012 |
Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm.
Topics: Aged; Antithrombin III; Arginine; Atrial Fibrillation; Catheter Ablation; CD40 Ligand; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Heart Atria; Heart Rate; Humans; Male; Middle Aged; P-Selectin; Peptide Hydrolases; Platelet Activation; Risk Assessment; Risk Factors; Statistics as Topic; Stroke; Thrombosis | 2013 |
Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction.
Topics: Arginine; Cerebrovascular Circulation; DNA Methylation; Homocysteine; Humans; Hyperhomocysteinemia; Oxidative Stress; Reactive Oxygen Species; Risk Factors; Stroke | 2004 |
Homocysteine, vitamin B6, and endothelial dysfunction in circulatory disorders.
Topics: Arginine; C-Reactive Protein; Endothelium, Vascular; Homocysteine; Humans; Nitric Oxide; Pyridoxal Phosphate; Stroke; Vitamin B 6; Vitamin B 6 Deficiency | 2004 |
Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population.
Topics: Acute Disease; Aged; Arginine; Biomarkers; Cerebral Hemorrhage; Cerebral Infarction; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Ischemic Attack, Transient; Male; Multivariate Analysis; Nitric Oxide Synthase; Odds Ratio; Risk Factors; Stroke | 2006 |
Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg.
Topics: Adult; Arginine; Biomarkers; Cohort Studies; Female; Follow-Up Studies; Homocysteine; Humans; Longitudinal Studies; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Sweden | 2008 |
Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke.
Topics: Aged; Aged, 80 and over; Arginine; Cerebral Infarction; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Female; Homocysteine; Humans; Logistic Models; Male; Nitric Oxide Synthase; Recurrence; Risk Factors; Stroke | 2001 |